Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Call Transcript

Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $0.03182 EPS, expectations were $0.2. Krystal Biotech, Inc.

Keep Reading →